Furthermore, the levels of p53 and its isoforms were associated with the enrichment of genetic alterations in p53 interactors BRCA1, PALB2 and CHEK2, which are genes with known impact on breast cancer outcomes. This evidence concerns the gene CHEK2 and breast cancer.